Clearly it's the season of magical thinking, as former adviser to current Mar-a-Lago resident Donald Trump was pushing quite the MAGAt's wet dream about how his ex-boss would be handling the newest variant of COVID-19, the Omicron strain.
Here's Stephen Miller on Fox "News," engaging in pure fantasy about his former boss: "If president Trump was still in office, by the way, we'd already have modified vaccines to deal with the variants, which is a great point. President Trump brought us vaccines in record time, which he made voluntary, not mandatory, and he'd have updates, too!"
Oh, Stephen. If you had more hair, the slightest grasp on reality, and an ounce of talent, I'd half-expect you to break into Aerosmith's "Dream On." Since you don't, allow me to spell things out.
If TFG was still in office, he'd be blaming Black people for the new variants, since this one was first detected in Botswana and South Africa. If he was still in office, he'd be trying to figure out how to profit off the vaccine, and buying stock in Regeneron. If he was still in office, he'd be doing everything he possibly could to block vaccine access and development, and silencing scientists.
The absolute last thing he'd be doing is making sure we know all we can about the variant, and doing all he can to use the federal government's resources to protect our citizens from getting sick and dying.
Here's what we do know so far, according to an article in The Atlantic:
What’s known so far absolutely warrants attention—not panic. Viruses mutate; they always do. Not all variants of concern turn out to be, well, all that concerning; many end up being mere blips in the pandemic timeline. As Omicron knocks up against its viral competitors, it may struggle to gain a toehold; it could yet be quelled through a combination of vaccines and infection-prevention measures such as masks and distancing. Vaccine makers have already announced plans to test their shots’ effectiveness against the new variant—with data to emerge in the coming weeks—and explore new dosing strategies that might help tamp down its spread. Omicron might be set up for some success, but a lot of its future also depends on us.